Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Slack Stock Is At an Inflection Point And Looks Expensive Here

By Mark R. Hake, CFA

Slack is at an inflection point with growing free cash flow. Slack stock assumes sales will grow over 33% annually over the next 3 years.

5 Cheap Stocks to Buy With High Yield and Good Earnings Power

By Mark R. Hake, CFA

These high-yield stocks also provide great earnings power. That said, all five of these names represent some of the top cheap stocks to buy.

Microsoft Gets Stronger as Free Cash Flow Grows

By Mark R. Hake, CFA

Microsoft goes from strength to strength as its free cash flow grows. MSFT stock will hit $2 trillion, or $263.62, based on a 3% FCF yield and similar FCF growth as last year.

Do Not Chase Tesla Stock After It Rallied 50%

By Mark R. Hake, CFA

Tesla stock shot up on news of its 5-for-1 stock split, but investors are better off waiting for a pullback or correction to buy shares.

Ocugen Stock Looks Like a Really Good Short Candidate Here

By Mark R. Hake, CFA

There's a good deal of downside risk, but Ocugen is worth a look. OCGN stock is likely to fall as Ocugen raises $30 million or 54% of its equity to fund operations over the next 2 plus years.

Intel’s Buyback Is Brilliant Given Its Cheap Valuation

By Mark R. Hake, CFA

The Intel stock buyback move is brilliant, given its cheap valuation. It will allows the dividend per share to rise at no higher cost.

CureVac Is a Bet on a Safe and Effective Vaccine

By Mark R. Hake, CFA

CureVac is a bet on a winning Covid-19 vaccine that is effective and safe. Buying CureVac stock could produce a 27.5% annual compounded return over the next two years.

Whiting Petroleum Will Emerge From Bankruptcy Looking Weak

By Mark R. Hake, CFA

Whiting Petroleum will emerge from bankruptcy on Sept. 1 very weakened. Don't bother buying WLL stock until its future becomes clearer.

Square Stock Will Keep Rising as Cash App Drives Massive Growth

By Mark R. Hake, CFA

Square is likely to keep on rising as Cash App takes over its growth. SQ stock is likely to triple over the next three to four years, as Cash App pushes its valuation close to PayPal's.

Exxon Mobil’s Commitment To Its Dividend Is Pushing Its Yield Higher

By Mark R. Hake, CFA

Exxon's dividend commitment is pushing the yield higher. At an 8.5% dividend yield today, Exxon Mobil stock could keep falling anyway.

Load More